BARX1 (F2K3K) Rabbit mAb #42301
- WB
Supporting Data
| REACTIVITY | H |
| SENSITIVITY | Endogenous |
| MW (kDa) | 30 |
| Source/Isotype | Rabbit IgG |
Application Key:
- WB-Western Blotting
Species Cross-Reactivity Key:
- H-Human
Product Information
Product Usage Information
| Application | Dilution |
|---|---|
| Western Blotting | 1:1000 |
Storage
Protocol
Specificity / Sensitivity
BARX1 (F2K3K) Rabbit mAb recognizes endogenous levels of total BARX1 protein.
Species Reactivity:
Human
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly245 of human BARX1 protein.
Background
BARX homeobox 1 (BARX1) is a transcription factor (TF) that was first isolated from mouse embryos and identified to function as a repressive TF by directly binding to the NCAM promoter and inhibiting its transcription (1). BARX1 also plays a key role in cellular differentiation and cytoskeletal remodeling in various tissues such as stomach, intestine, and spleen (2-4). Several studies have also established a key role for this TF in the proliferation and metastasis of many tumors. Namely, BARX1 was shown to promote the proliferation of oesophageal adenocarcinoma and renal cell carcinoma (5,6) and was identified as one of the top ten oncogenic TFs that are critical in non-small cell lung cancer (7). Moreover, silencing of BARX1 in endometrial carcinoma cells was shown to suppress ERK/MEK signaling pathway activity and reduce cell viability (8).
- Tissier-Seta, J.P. et al. (1995) Mech Dev 51, 3-15.
- Kim, B.M. et al. (2005) Dev Cell 8, 611-22.
- Makarenkova, H.P. and Meech, R. (2012) Int Rev Cell Mol Biol 297, 117-73.
- Jayewickreme, C.D. and Shivdasani, R.A. (2015) Dev Biol 405, 21-32.
- Becker, J. et al. (2015) Cancer Med 4, 1700-4.
- Sun, G. et al. (2021) Front Mol Biosci 8, 626328.
- Zhang, D.L. et al. (2018) Cancer Lett 434, 132-143.
- Lu, Y. et al. (2021) Reprod Biol 21, 100502.
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.